Characterization of a naloxone-insensitive β-endorphin receptor on murine peritoneal macrophages

Jeffrey A. Woods, Nahid A. Shahabi, Burt Sharp

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Previous studies from our laboratory have characterized a naloxone-insensitive β-Endorphin (β-End) receptor on the human pro-monocytic cell line U937. Since monocytes are macrophage precursors, we sought to identify and characterize this site on fully differentiated effector macrophages. Mice (ICR females, 6-8 wk old) were injected (i.p.) with 1 mL of thioglycollate to induce an inflammatory response. Elicited cells were harvested 3 d later by lavage. Macrophages were enriched by adherence and analyzed via radioreceptor assay (with [125I]β-End, 2,000 Ci · mmol-1) as either intact cells or membrane preparations. Scatchard analysis revealed a single saturable binding site for β-End (K(d) = 9.75 ± 2.6 x 10-9 M; 8218 ± 2360 sites/cell). Competition studies showed that other opiate receptor ligands including naloxone, DAMGO, U69593, or 2,5 DPDP-enkephalin were ineffective at displacing [125I]β-End when compared to unlabeled β-End. Analysis of competition studies utilizing fragments and analogs of β-End revealed that β-End (6-31) and β-End (1-5, 16-31) were equipotent, and N-acetylated β-End was less potent, than β-End (1-31) in displacing [125I]β-End binding. In contrast, β-End (1-27) and β-End (28-31) were ineffective. In summary, we have identified a naloxone-resistant β-End binding site on murine peritoneal macrophages that is similar to one we have previously characterized on U937 cells and cultured murine splenocytes.

Original languageEnglish (US)
Pages (from-to)573-586
Number of pages14
JournalLife Sciences
Volume60
Issue number9
DOIs
StatePublished - Jan 24 1997

Fingerprint

Macrophages
Peritoneal Macrophages
Opioid Receptors
Naloxone
Binding Sites
Ala(2)-MePhe(4)-Gly(5)-enkephalin
Thioglycolates
Inbred ICR Mouse
Radioligand Assay
U937 Cells
Enkephalins
Therapeutic Irrigation
Monocytes
Cell Membrane
Ligands
Cell Line
Assays
Cells
Membranes

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Characterization of a naloxone-insensitive β-endorphin receptor on murine peritoneal macrophages. / Woods, Jeffrey A.; Shahabi, Nahid A.; Sharp, Burt.

In: Life Sciences, Vol. 60, No. 9, 24.01.1997, p. 573-586.

Research output: Contribution to journalArticle

Woods, Jeffrey A. ; Shahabi, Nahid A. ; Sharp, Burt. / Characterization of a naloxone-insensitive β-endorphin receptor on murine peritoneal macrophages. In: Life Sciences. 1997 ; Vol. 60, No. 9. pp. 573-586.
@article{28d3165e632042aca2177b784fc61b20,
title = "Characterization of a naloxone-insensitive β-endorphin receptor on murine peritoneal macrophages",
abstract = "Previous studies from our laboratory have characterized a naloxone-insensitive β-Endorphin (β-End) receptor on the human pro-monocytic cell line U937. Since monocytes are macrophage precursors, we sought to identify and characterize this site on fully differentiated effector macrophages. Mice (ICR females, 6-8 wk old) were injected (i.p.) with 1 mL of thioglycollate to induce an inflammatory response. Elicited cells were harvested 3 d later by lavage. Macrophages were enriched by adherence and analyzed via radioreceptor assay (with [125I]β-End, 2,000 Ci · mmol-1) as either intact cells or membrane preparations. Scatchard analysis revealed a single saturable binding site for β-End (K(d) = 9.75 ± 2.6 x 10-9 M; 8218 ± 2360 sites/cell). Competition studies showed that other opiate receptor ligands including naloxone, DAMGO, U69593, or 2,5 DPDP-enkephalin were ineffective at displacing [125I]β-End when compared to unlabeled β-End. Analysis of competition studies utilizing fragments and analogs of β-End revealed that β-End (6-31) and β-End (1-5, 16-31) were equipotent, and N-acetylated β-End was less potent, than β-End (1-31) in displacing [125I]β-End binding. In contrast, β-End (1-27) and β-End (28-31) were ineffective. In summary, we have identified a naloxone-resistant β-End binding site on murine peritoneal macrophages that is similar to one we have previously characterized on U937 cells and cultured murine splenocytes.",
author = "Woods, {Jeffrey A.} and Shahabi, {Nahid A.} and Burt Sharp",
year = "1997",
month = "1",
day = "24",
doi = "10.1016/S0024-3205(96)00640-6",
language = "English (US)",
volume = "60",
pages = "573--586",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Characterization of a naloxone-insensitive β-endorphin receptor on murine peritoneal macrophages

AU - Woods, Jeffrey A.

AU - Shahabi, Nahid A.

AU - Sharp, Burt

PY - 1997/1/24

Y1 - 1997/1/24

N2 - Previous studies from our laboratory have characterized a naloxone-insensitive β-Endorphin (β-End) receptor on the human pro-monocytic cell line U937. Since monocytes are macrophage precursors, we sought to identify and characterize this site on fully differentiated effector macrophages. Mice (ICR females, 6-8 wk old) were injected (i.p.) with 1 mL of thioglycollate to induce an inflammatory response. Elicited cells were harvested 3 d later by lavage. Macrophages were enriched by adherence and analyzed via radioreceptor assay (with [125I]β-End, 2,000 Ci · mmol-1) as either intact cells or membrane preparations. Scatchard analysis revealed a single saturable binding site for β-End (K(d) = 9.75 ± 2.6 x 10-9 M; 8218 ± 2360 sites/cell). Competition studies showed that other opiate receptor ligands including naloxone, DAMGO, U69593, or 2,5 DPDP-enkephalin were ineffective at displacing [125I]β-End when compared to unlabeled β-End. Analysis of competition studies utilizing fragments and analogs of β-End revealed that β-End (6-31) and β-End (1-5, 16-31) were equipotent, and N-acetylated β-End was less potent, than β-End (1-31) in displacing [125I]β-End binding. In contrast, β-End (1-27) and β-End (28-31) were ineffective. In summary, we have identified a naloxone-resistant β-End binding site on murine peritoneal macrophages that is similar to one we have previously characterized on U937 cells and cultured murine splenocytes.

AB - Previous studies from our laboratory have characterized a naloxone-insensitive β-Endorphin (β-End) receptor on the human pro-monocytic cell line U937. Since monocytes are macrophage precursors, we sought to identify and characterize this site on fully differentiated effector macrophages. Mice (ICR females, 6-8 wk old) were injected (i.p.) with 1 mL of thioglycollate to induce an inflammatory response. Elicited cells were harvested 3 d later by lavage. Macrophages were enriched by adherence and analyzed via radioreceptor assay (with [125I]β-End, 2,000 Ci · mmol-1) as either intact cells or membrane preparations. Scatchard analysis revealed a single saturable binding site for β-End (K(d) = 9.75 ± 2.6 x 10-9 M; 8218 ± 2360 sites/cell). Competition studies showed that other opiate receptor ligands including naloxone, DAMGO, U69593, or 2,5 DPDP-enkephalin were ineffective at displacing [125I]β-End when compared to unlabeled β-End. Analysis of competition studies utilizing fragments and analogs of β-End revealed that β-End (6-31) and β-End (1-5, 16-31) were equipotent, and N-acetylated β-End was less potent, than β-End (1-31) in displacing [125I]β-End binding. In contrast, β-End (1-27) and β-End (28-31) were ineffective. In summary, we have identified a naloxone-resistant β-End binding site on murine peritoneal macrophages that is similar to one we have previously characterized on U937 cells and cultured murine splenocytes.

UR - http://www.scopus.com/inward/record.url?scp=0031584677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031584677&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(96)00640-6

DO - 10.1016/S0024-3205(96)00640-6

M3 - Article

VL - 60

SP - 573

EP - 586

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 9

ER -